| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000215863.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019438491 |
Resistant |
| ENSG00000215863.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004147812 |
Resistant |
| ENSG00000215863.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001863017 |
Resistant |
